1. Home
  2. PMVP vs MAIA Comparison

PMVP vs MAIA Comparison

Compare PMVP & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • MAIA
  • Stock Information
  • Founded
  • PMVP 2013
  • MAIA 2018
  • Country
  • PMVP United States
  • MAIA United States
  • Employees
  • PMVP N/A
  • MAIA N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • MAIA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMVP Health Care
  • MAIA Health Care
  • Exchange
  • PMVP Nasdaq
  • MAIA Nasdaq
  • Market Cap
  • PMVP 85.5M
  • MAIA 62.4M
  • IPO Year
  • PMVP 2020
  • MAIA 2022
  • Fundamental
  • Price
  • PMVP $1.65
  • MAIA $2.82
  • Analyst Decision
  • PMVP Strong Buy
  • MAIA
  • Analyst Count
  • PMVP 4
  • MAIA 0
  • Target Price
  • PMVP $5.75
  • MAIA N/A
  • AVG Volume (30 Days)
  • PMVP 185.0K
  • MAIA 60.0K
  • Earning Date
  • PMVP 11-07-2024
  • MAIA 11-05-2024
  • Dividend Yield
  • PMVP N/A
  • MAIA N/A
  • EPS Growth
  • PMVP N/A
  • MAIA N/A
  • EPS
  • PMVP N/A
  • MAIA N/A
  • Revenue
  • PMVP N/A
  • MAIA N/A
  • Revenue This Year
  • PMVP N/A
  • MAIA N/A
  • Revenue Next Year
  • PMVP N/A
  • MAIA N/A
  • P/E Ratio
  • PMVP N/A
  • MAIA N/A
  • Revenue Growth
  • PMVP N/A
  • MAIA N/A
  • 52 Week Low
  • PMVP $1.33
  • MAIA $0.82
  • 52 Week High
  • PMVP $3.47
  • MAIA $5.99
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 60.86
  • MAIA 50.98
  • Support Level
  • PMVP $1.63
  • MAIA $2.36
  • Resistance Level
  • PMVP $1.69
  • MAIA $2.72
  • Average True Range (ATR)
  • PMVP 0.07
  • MAIA 0.22
  • MACD
  • PMVP 0.01
  • MAIA 0.02
  • Stochastic Oscillator
  • PMVP 52.65
  • MAIA 72.28

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Share on Social Networks: